JSC Grindeks confirms that the turnover of the company’s (not the Group’s) self-manufactured products in 2012 was 55.5 million lats, based on the State Agency...
Environmental Control Laboratory of JSC Grindeks has received the accreditation certificate ISO 17025 from the Latvian National Accreditation Bureau. The received accreditation certifies the proficiency...
Today, on 28 November 2012, in Riga, 53 Krustils Street, JSC Grindeks has solemnly unveiled a manufacturing unit of ointments and gels, which is one...
Today, on 8 November, within the framework of the World Science Day, JSC Grindeks fund “For the Support of Science and Education” in cooperation with...
Grindeks’ Main fields of action are research, development, manufacturing and sales of original products, generics and active pharmaceutical ingredients. Grindeks Group consists of 4 subsidiary companies...
JSC Grindeks informs that today, on 21 September, the delegation of Japanese entrepreneurs is visiting the company. The visit is within the framework of the...
From 9 to 11 October, 2012, Grindeks will participate in the international exhibition “CPhI Worldwide 2012” in Madrid, Spain. During the exhibition Grindeks will meet...
International conference “Life Sciences Baltics 2012” takes place in Vilnius, Lithuania from 12 until 14 September, where, besides other leading pharmaceutical specialists, Chairman of the...
On 7-9 September, the International Medical Meeting (IMM-Riga 2012) will take place in the University of Latvia in Riga, Latvia. In the IMM, scientists will...
Grindeks informs that the company is expanding its presence in the CIS countries and opens new representative office in Armenia. The representative office will cooperate...
Today, on 9 July 2012, a cooperation agreement was concluded between Grindeks and the Latvian University on the long-term cooperation in scientific research, technology transfer,...
JSC Grindeks informs that the company has submitted its Corporate Social Responsibility Reportof 2011 to “Nasdaq OMX Riga”. Corporate Social Responsibility policy of «Grindeks» is...
Grindeks informs that the manufactured medication by the company Amitriptyline-Grindeks has received an award for “The best anti-depressant in somatic practice” in the international award...
Today, on 29 May, Grindeks participates in the conference “CEO Meets Investor”, organized by “Nasdaq OMX Baltic”, held in Vilnius, Lithuania. During the conference, Grindeks...
